Recently, Jiangzhong Pharmaceutical Co., Ltd. announced its intention to change its stock abbreviation from “Jiangzhong Pharmaceutical” to “China Resources Jiangzhong.” This move aims to more accurately reflect the company’s current ownership structure and brand affiliation. Since China Resources Pharmaceutical officially acquired control of Jiangzhong in 2019, the company has been deeply integrated into the China Resources Group’s health and wellness ecosystem, benefiting significantly from strategic alignment, management support, and resource synergy. The proposed name change not only reinforces the strong endorsement of the state-owned China Resources brand but also enhances market recognition of the company’s overall strength and future growth potential. The new stock name better represents Jiangzhong’s strategic role as the core platform for traditional Chinese medicine (TCM) within the China Resources Group, facilitating brand integration and business synergy. The change is pending approval by the Shanghai Stock Exchange before it becomes effective. Industry observers widely view this renaming as a key step in Jiangzhong’s deepening state-owned enterprise reform and its acceleration toward high-quality development, which is expected to bolster investor confidence and enhance corporate value.As a well-known TCM enterprise in China, Jiangzhong is recognized for iconic products such as “Jianwei Xiaoshi Tablets” and “Compound Herba Sarcandrae Lozenges.” Leveraging China Resources’ extensive resources, the company is accelerating its efforts in modernizing and internationalizing TCM while expanding its footprint in the broader health and wellness industry.
近日，江中药业股份有限公司发布公告，拟将公司证券简称由“江中药业”变更为“华润江中”。此举旨在更准确地反映公司当前的股权结构与品牌归属。自2019年华润医药正式控股江中药业以来，公司已深度融入华润集团大健康体系，在战略、管理、资源协同等方面获得显著支持。此次更名不仅强化了“华润”这一央企品牌背书，也有助于提升市场对公司整体实力和未来发展前景的认知。变更后的证券简称将更好地体现公司作为华润集团旗下中医药板块核心平台的战略定位，进一步推动品牌整合与业务协同发展。目前，该变更尚需经上海证券交易所审核批准后方可正式实施。业内普遍认为，此次更名是江中药业深化国企改革、加速高质量发展的重要一步，有望增强投资者信心并提升企业价值。江中药业作为国内知名的中药企业，拥有如“健胃消食片”“复方草珊瑚含片”等经典产品，在消费者中具有较高知名度。依托华润集团的资源优势，公司正加快在中医药现代化、国际化以及大健康产业布局方面的步伐。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/17546.html